A Boston startup hoping to leverage the gastrointestinal and immune systems to create drugs for psychiatric disorders plans to launch an IPO in the coming months.
Karuna Therapeutics has filed documents with the SEC to begin trading on the stock market, the company disclosed Friday. The documents were not filed publicly, and Karuna declined to state how many shares and at what price it proposed selling its stock.
The startup was founded in 2009 by Boston’s PureTech Health, which starts and…
Boston Biz Journal https://www.bizjournals.com/boston/news/2019/04/29/boston-based-psychiatric-drugmaker-karuna-plans.html?ana=RSS&s=article_search